An Integrated Assessment of the Safety and Effectiveness of Bexagliflozin for the Management of Essential Hypertension

Completed · Phase 2/Phase 3 · Has a placebo group

Conditions studied: Essential Hypertension

In brief

This integrated assessment consists of two studies, 603A and 603B, to be carried out sequentially in a common study population. Participating subjects informed of the trial design and their consent to participate in both studies were to be obtained in a single consent form. Approximately 680 male or female adult subjects were to be enrolled.

Key facts

Study ID
NCT03514641
Run by
Theracos
People needed
673
Starts
2017-10-18
Expected to finish
2018-11-30
Last updated by the study team
2021-09-21

Who can join

Age: 20 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.